Clinical trials: Comprehensive Genomic
LBCL, Comprehensive Genomic
PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL
To determine whether special laboratory tests, called genomic sequencing, can identify specific subtypes of LBCL and provide information that may help guide treatment decisions.
- Conditions
- LBCL, Comprehensive Genomic, Precision Treatment
- Trial name
- NCT07829445
- Testing
- Standard of Care (SOC)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- M.D. Anderson Cancer Center